These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3143587)

  • 1. In vitro activity of florphenicol.
    Graham R; Palmer D; Pratt BC; Hart CA
    Eur J Clin Microbiol Infect Dis; 1988 Oct; 7(5):691-4. PubMed ID: 3143587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro acitvity of chloramphenicol and thiamphenicol on common aerobic and anaerobic gram-negative bacilli(Salmonella and Shigella excluded).
    Beers DV; Schoutens E; Vanderlinden MP; Yourassowsky E
    Chemotherapy; 1975; 21(2):73-81. PubMed ID: 1097209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol.
    Syriopoulou VP; Harding AL; Goldmann DA; Smith AL
    Antimicrob Agents Chemother; 1981 Feb; 19(2):294-7. PubMed ID: 6957162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of chloramphenicol and thiamphenicol analogs.
    Neu HC; Fu KP
    Antimicrob Agents Chemother; 1980 Aug; 18(2):311-6. PubMed ID: 7447408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents --special references to bacteria isolated between April 2008 and March 2009].
    Shinagawa N; Hasegawa M; Hirata K; Furuhata T; Mizukuchi T; Osanai H; Yanai Y; Hata F; Sasaki K; Someya T; Harada K; Oono K; Tokita S; Nakamura M; Shibuya H; Hasegawa I; Kimura M; Oshima H; Maeda H; Mukaiya M; Kihara C; Kosho W; Hoshikawa T; Kimura H; Ushijima Y; Yae-Hoon Y; Aikawa N; Abe S; Yura J; Takeyama H; Wakasugi T; Taniguchi M; Mizuno I; Fukui T; Mashita K; Ishikawa S; Mizuno A; Moori N; Sumita N; Kubo S; Lee S; Oomura T; Kobayashi Y; Tsuji T; Yamaue H; Kawai M; Takesue Y; Tanaka N; Kimura H; Iwagaki H; Sueda T; Hiyama E; Murakami Y; Ooge H; Uemura K; Tsumura H; Yokoyama T; Takeuchi H; Tanakaya K; Yasunami Y; Ryu S
    Jpn J Antibiot; 2010 Apr; 63(2):105-70. PubMed ID: 20919496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thiamphenicol and chloramphenicol: an in vitro comparison with particular reference to bactericidal activity.
    O'Grady F; Pearson NJ; Dennis C
    Chemotherapy; 1980; 26(2):116-20. PubMed ID: 7363705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro study of the antibacterial effect of cefotetan against gram-positive and gram-negative aerobic and anaerobic strains from fresh clinical isolates.
    Klietmann W; Focht J; Nösner K
    Chemioterapia; 1987 Jun; 6(2 Suppl):92-3. PubMed ID: 3509542
    [No Abstract]   [Full Text] [Related]  

  • 9. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteria isolated from surgical infections and its susceptibilities to antimicrobial agents--special references to bacteria isolated between April 2003 and March 2004].
    Shinagawa N; Taniguchi M; Hirata K; Katsuramaki T; Mizukuchi T; Mashita K; Ushijima Y; Ushida T; Ishikawa S; Aikawa N; Yo K; Mizuno A; Takayama T; Sato T; Kato K; Kubo S; Suehiro S; Yura J; Fujimoto M; Manabe T; Takeyama H; Tanimura H; Taniguchi K; Hasegawa M; Yamaue H; Ohnishi H; Tanaka N; Iwagaki H; Kimura H; Tsumura H; Fuchimoto S; Yokoyama T; Sueda T; Takesue Y; Takeuchi H; Yasui Y; Hiyama E; Ikeda S; Yasunami Y
    Jpn J Antibiot; 2006 Apr; 59(2):72-116. PubMed ID: 16805318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents. Special references to bacteria isolated between July 1995 and June 1996].
    Shinagawa N; Koide H; Hirata K; Denno R; Mukaiya M; Ishibiki K; Ushijima Y; Aikawa N; Takuma K; Iwai S; Kunimatsu M; Ohtsuka K; Yura J; Manabe T; Mashita K; Ishikawa S; Mizuno A; Kinoshita H; Morimoto K; Fujimoto M; Tanimura H; Ohnishi H; Sakaguchi S; Dounishi H; Oda S
    Jpn J Antibiot; 1997 Feb; 50(2):143-77. PubMed ID: 9100076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Susceptibility to Thiamphenicol and Chloramphenicol of Anaerobic Bacteria (author's transl)].
    Werner H; Krasemann C; Gorniak W; Hermann A; Ungerechts J
    Zentralbl Bakteriol Orig A; 1977; 237(2-3):358-71. PubMed ID: 848218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates.
    Felmingham D; Robbins MJ; Ingley K; Mathias I; Bhogal H; Leakey A; Ridgway GL; Grüneberg RN
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():43-9. PubMed ID: 9222069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy.
    Marchese A; Debbia EA; Tonoli E; Gualco L; Schito AM
    J Chemother; 2002 Dec; 14(6):554-61. PubMed ID: 12583545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of meropenem against clinical isolates in a multicentre study in Italy.
    Schito GC; Sanna A; Chezzi C; Ravizzola G; Leone F; Molinari G; Menozzi MG; Pirali F
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():57-72. PubMed ID: 2681128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-vitro antibacterial activity of Sch 25393, a fluorinated analogue of thiamphenicol.
    Marca G; Mattina R; Dubini F; Cocuzza G
    J Antimicrob Chemother; 1984 May; 13(5):423-7. PubMed ID: 6376457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in-vitro activity of PD127,391, a new quinolone.
    King A; Boothman C; Phillips I
    J Antimicrob Chemother; 1988 Aug; 22(2):135-41. PubMed ID: 3182416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of ertapenem (MK-0826), a long-acting carbapenem, tested against selected resistant strains.
    Jones RN
    J Chemother; 2001 Aug; 13(4):363-76. PubMed ID: 11589478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin.
    Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D
    J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.